Filing Details

Accession Number:
0000791908-17-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-23 10:45:30
Reporting Period:
2017-03-21
Filing Date:
2017-03-23
Accepted Time:
2017-03-23 10:45:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1600865 R James Neal C/O Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Vp Business Development Yes Yes No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2017-03-21 5,105 $5.40 15,366 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,961 Indirect by 401(k)
Footnotes
  1. Indirect ownership includes shares acquired from a 401(k) match accumulated during 2016 and purchased on 1/26/2017, deemed not reportable.
  2. Shares sold on the open market to satisfy the taxes required to be withheld in connection with the vesting of the shares in a non-discretionary transaction pursuant to the reporting person's agreement under the Company's incentive plan.
  3. Shares sold at multiple prices between $5.4002 and $5.4004 with a weighted average sale price of $5.40038.
  4. Includes unvested RSUs previously reported on Table I.